529 related articles for article (PubMed ID: 28833467)
1. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
Iranzo A; Santamaría J; Valldeoriola F; Serradell M; Salamero M; Gaig C; Niñerola-Baizán A; Sánchez-Valle R; Lladó A; De Marzi R; Stefani A; Seppi K; Pavia J; Högl B; Poewe W; Tolosa E; Lomeña F
Ann Neurol; 2017 Sep; 82(3):419-428. PubMed ID: 28833467
[TBL] [Abstract][Full Text] [Related]
2. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
[TBL] [Abstract][Full Text] [Related]
3. Reduced dopamine transporter binding predicts early transition to Lewy body disease in Japanese patients with idiopathic rapid eye movement sleep behavior disorder.
Miyamoto T; Miyamoto M; Numahata K; Onoue H; Akaiwa Y; Sairenchi T
J Neurol Sci; 2020 Jul; 414():116821. PubMed ID: 32330698
[TBL] [Abstract][Full Text] [Related]
4. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder.
Chahine LM; Brumm MC; Caspell-Garcia C; Oertel W; Mollenhauer B; Amara A; Fernandez-Arcos A; Tolosa E; Simonet C; Hogl B; Videnovic A; Hutten SJ; Tanner C; Weintraub D; Burghardt E; Coffey C; Cho HR; Kieburtz K; Poston KL; Merchant K; Galasko D; Foroud T; Siderowf A; Marek K; Simuni T; Iranzo A
Ann Clin Transl Neurol; 2021 Jan; 8(1):201-212. PubMed ID: 33321002
[TBL] [Abstract][Full Text] [Related]
6. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.
Zoetmulder M; Nikolic M; Biernat H; Korbo L; Friberg L; Jennum P
J Clin Sleep Med; 2016 Jun; 12(6):895-903. PubMed ID: 27070245
[TBL] [Abstract][Full Text] [Related]
7. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
[TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
Iranzo A; Tolosa E; Gelpi E; Molinuevo JL; Valldeoriola F; Serradell M; Sanchez-Valle R; Vilaseca I; Lomeña F; Vilas D; Lladó A; Gaig C; Santamaria J
Lancet Neurol; 2013 May; 12(5):443-53. PubMed ID: 23562390
[TBL] [Abstract][Full Text] [Related]
9. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
Arnaldi D; Chincarini A; Hu MT; Sonka K; Boeve B; Miyamoto T; Puligheddu M; De Cock VC; Terzaghi M; Plazzi G; Tachibana N; Morbelli S; Rolinski M; Dusek P; Lowe V; Miyamoto M; Figorilli M; Verbizier D; Bossert I; Antelmi E; Meli R; Barber TR; Trnka J; Miyagawa T; Serra A; Pizza F; Bauckneht M; Bradley KM; Zogala D; McGowan DR; Jordan L; Manni R; Nobili F
Brain; 2021 Feb; 144(1):278-287. PubMed ID: 33348363
[TBL] [Abstract][Full Text] [Related]
11. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
[TBL] [Abstract][Full Text] [Related]
12. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.
Rupprecht S; Walther B; Gudziol H; Steenbeck J; Freesmeyer M; Witte OW; Günther A; Schwab M
Sleep Med; 2013 Nov; 14(11):1064-70. PubMed ID: 23948220
[TBL] [Abstract][Full Text] [Related]
13. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
Shin JH; Lee JY; Kim YK; Shin SA; Kim H; Nam H; Jeon B
Neurology; 2020 Dec; 95(23):e3081-e3092. PubMed ID: 32989104
[TBL] [Abstract][Full Text] [Related]
15. Striatal dopamine transporter degeneration in right-handed REM sleep behavior disorder patients progresses faster in the left hemisphere.
Miyamoto T; Akaiwa Y; Numahata K; Yoshizawa K; Sairenchi T; Miyamoto M
Parkinsonism Relat Disord; 2022 Feb; 95():107-112. PubMed ID: 35093712
[TBL] [Abstract][Full Text] [Related]
16. Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases.
Li Y; Kang W; Yang Q; Zhang L; Zhang L; Dong F; Chen S; Liu J
Neurology; 2017 Apr; 88(16):1493-1500. PubMed ID: 28330956
[TBL] [Abstract][Full Text] [Related]
17. Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases.
Soto M; Iranzo A; Lahoz S; Fernández M; Serradell M; Gaig C; Melón P; Martí MJ; Santamaría J; Camps J; Fernández-Santiago R; Ezquerra M
Mov Disord; 2022 Oct; 37(10):2086-2098. PubMed ID: 35962561
[TBL] [Abstract][Full Text] [Related]
18. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
[TBL] [Abstract][Full Text] [Related]
19. The fate of patients with REM sleep behavior disorder and mild cognitive impairment.
Arnaldi D; Chincarini A; De Carli F; Famà F; Girtler N; Brugnolo A; Pardini M; Massa F; Meli R; Schenone C; Bauckneht M; Morbelli S; Nobili F
Sleep Med; 2021 Mar; 79():205-210. PubMed ID: 32451160
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [
Fujishiro H; Okuda M; Iwamoto K; Miyata S; Torii Y; Iritani S; Ozaki N
Psychiatry Clin Neurosci; 2018 Jun; 72(6):423-434. PubMed ID: 29536584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]